Patents Assigned to CELLESTIS INTERNATIONAL PTY LTD.
  • Diagnostic assay
    Patent number: 10578612
    Abstract: The present disclosure relates generally to the field of immunological-based diagnostic assays. Particularly, a method is contemplated herein for measuring cell-mediated immune response reactivity. The present disclosure further provides a method to reduce incidence of non-specific immune response reactivity in a cell-mediated immune response-based assay, comprising contacting a sample with a basic peptide structure capable of binding to lipopolysaccharides, such as polymyxin B or a sushi peptide.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: March 3, 2020
    Assignee: Cellestis International Pty Ltd.
    Inventors: Anthony J. Radford, Emily Manktelow, Jeff Boyle, Jenny Louise Howard
  • DIAGNOSTIC ASSAY
    Publication number: 20130289139
    Abstract: The present disclosure relates generally to the field of immunological-based diagnostic assays. Particularly, a method is contemplated herein for measuring cell-mediated immune response reactivity. The present disclosure further provides a method to reduce incidence of non-specific immune response reactivity in a cell-mediated immune response-based assay, comprising contacting a sample with a basic peptide structure capable of binding to lipopolysaccharides, such as polymyxin B or a sushi peptide.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 31, 2013
    Applicant: CELLESTIS INTERNATIONAL PTY LTD.
    Inventors: Anthony J. Radford, Emily Manktelow, Jeff Boyle, Jenny Louise Howard